Suboxone Alternatives Compared
| Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone | Buprenorphine |
|
|---|
| Suboxone (buprenorphine / naloxone) | Buprenorphine / naloxone | Buprenorphine |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Suboxone is a combination medicine containing buprenorphine and naloxone that is used to treat adults addicted to opioid medications. It should be used in conjunction with a complete treatment... View more |
Prescription only
Buprenorphine/naloxone is a combination opioid/opioid antagonist tablet which helps to suppress opioid withdrawal symptoms and is used for the maintenance treatment of opioid drug dependence... View more |
Prescription only
Buprenorphine is a potent analgesic that should be only used to treat moderate to severe pain or for the treatment of opioid addiction under strict conditions. Different formulations of the drug... View more |
Related suggestions Opioid Use Disorder
|
|||||||||||||||||||||||
| More about Suboxone (buprenorphine / naloxone) | More about Buprenorphine / naloxone | More about Buprenorphine | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Suboxone has an average rating of 8.5 out of 10 from a total of 729 ratings on Drugs.com. 81% of reviewers reported a positive effect, while 7% reported a negative effect. |
Buprenorphine / naloxone has an average rating of 7.7 out of 10 from a total of 1131 ratings on Drugs.com. 70% of reviewers reported a positive effect, while 16% reported a negative effect. |
Buprenorphine has an average rating of 6.7 out of 10 from a total of 1153 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 25% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Suboxone side effects |
|
View all Buprenorphine side effects |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
Lower cost generic |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Suboxone prices |
View all Buprenorphine / naloxone prices |
View all Buprenorphine prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other buprenorphine / naloxone brands include: Zubsolv | Suboxone, Zubsolv | Belbuca, Brixadi, Buprenex, Butrans, Sublocade | ||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
37 hours |
37 hours |
48 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 723 drugs are known to interact with Suboxone:
|
A total of 723 drugs are known to interact with Buprenorphine / naloxone:
|
A total of 718 drugs are known to interact with Buprenorphine:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
October 08, 2002 |
October 08, 2002 |
December 29, 1981 |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Belbuca
Belbuca (buprenorphine) is used for chronic pain management. Includes Belbuca side effects ...
Subutex
Subutex (buprenorphine) is used to treat opioid addiction. Includes Subutex side effects ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Vivitrol
Vivitrol is a long-acting injectable form of naltrexone used to treat alcohol use disorder and ...
Sublocade
Sublocade information from Drugs.com, includes Sublocade side effects, interactions and indications.
Butrans
Butrans (buprenorphine) transdermal patches are used to treat moderate to severe chronic pain ...
Zubsolv
Zubsolv (buprenorphine and naloxone) is used to treat opioid dependence. Includes Zubsolv side ...
Brixadi
Brixadi (buprenorphine) is a weekly or monthly injection used to treat moderate to severe opioid ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.